OTC · MLCT
Malachite Innovations, Inc.
Healthcare · Biotechnology
$0.20
Up+$0.01 (+2.63%)
Updated Aug 13, 2026, 11:07 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 17.49M
- P/E ratio
- -22.51
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 18.29K
- Avg. volume
- 12.25K
Price performance
MLCT price history
1M range · 0 trading sessions · Daily adjusted prices
MLCT does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest MLCT news
The latest Smart Investors Daily articles mentioning MLCT.
Stock researchCompany · Overview
MLCT research
Overview
Company profile and research snapshot.
Company profile
Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
